Isocitrate dehydrogenase 1 mutation is associated with reduced levels of inflammation in glioma patients

Background: Glioma patients with mutant isocitrate dehydrogenase have improved survival; this could be in part due to the suppressive effect of mutant IDH on the level of chronic inflammation. This study aimed to prospectively analyze the association of IDH1 mutation status with preoperative levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Auezova, Raushan, Ivanova, Natalia, Akshulakov, Serik, Zhetpisbaev, Berik, Kozhakhmetova, Aizhan, Ryskeldiyev, Nurzhan, Mustafin, Khalit, Teltayev, Daniyar, Auezova, Lizette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489560/
https://www.ncbi.nlm.nih.gov/pubmed/31114362
http://dx.doi.org/10.2147/CMAR.S195754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489560/
https://www.ncbi.nlm.nih.gov/pubmed/31114362
http://dx.doi.org/10.2147/CMAR.S195754

Ejemplares similares